Effects of intracerebroventricular injection of rosiglitazone on appetite-associated parameters in chicks.
Sign Up to like & getrecommendations! Published in 2017 at "General and comparative endocrinology"
DOI: 10.1016/j.ygcen.2015.12.021
Abstract: Rosiglitazone, a thiazolidinedione, is a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist that increases insulin sensitivity. A documented side effect of this diabetes drug is increased appetite, although the mechanism mediating this response is unknown. To… read more here.
Keywords: food intake; rosiglitazone appetite; rosiglitazone; injection ... See more keywords